More Patrys Limited news
Patrys LimitedASX: PAB

Patrys adds full human antibody to Deoxymab portfolio

Sep 27, 2020 at 11:33 PM EDT · Issued by Patrys Limited

Filed with ASX · Sep 27, 2020 at 11:33 PM EDT

On 6ix: 6ix.com/news/patrys-adds-full-human-antibody-to-deoxymab-portfolio

Patrys Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Patrys Limited on 6ix

Story so far

  • Europe grants patent for Deoxymab 3E10Jul 17, 2019
  • China and Japan both grant patents for Deoxymab 3E10Jul 3, 2018

Earlier from Patrys

  • Appendix 4E and 2020 Annual ReportAug 24, 2020
  • Entitlement Offer Results and Shortfall NotificationAug 3, 2020
  • Appendix 4C - Quarterly - 30 June 2020Jul 30, 2020
  • $4.29 Million Fully Underwritten Rights IssueJun 22, 2020
  • Investor Presentation - June 2020Jun 17, 2020

Later from Patrys

  • First patent granted for Deoxymab-nanoparticlesOct 5, 2020
  • Appendix 4C - Quarterly - 30 September 2020Oct 25, 2020
  • Investor Presentation - November 2020Nov 4, 2020
  • Investor Presentation - November 2020 - UpdatedNov 5, 2020
  • $7.3M Capital RaisingNov 8, 2020
All Patrys news releases↗

Follow Patrys into a list and get an email when it puts out news.

Follow Patrys
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer